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Abstract
Background: As the United States braces for full implementation of health care reform, the eyes of the nation are
on Medicaid. The large number of newly eligible Medicaid beneficiaries may challenge health care resources and
ultimately impact quality of care. This is a special concern among current Medicaid beneficiaries such as children
with complex chronic conditions (CCCs) who have significant health care needs, especially at end of life (EOL).
Yet, a comprehensive profile of these children is lacking.
Objective: To understand the demographic and health characteristics, health care utilization, and expenditures
among Medicaid children with CCCs at EOL.
Methods: Our study used a retrospective cohort design with data from the 2007 and 2008 California Medicaid
data files. Descriptive statistics were used to profile children in the last year of life.
Results: We found a diverse group of children who suffered with serious, multiple chronic conditions, and who
accessed comprehensive, multidisciplinary care. Most children had neuromuscular conditions (54%), cardio-
vascular conditions (46%), and cancer (30%). A majority (56%) had multiple CCCs. Children with CCCs received
comprehensive care including hospital inpatient (67%), primary (82%), ancillary (87%), and other acute care
services (83%); however, few children utilized hospice and home health care services (26%). Significant age
differences existed among the children.
Conclusions: The current California Medicaid system appears to provide comprehensive care for children at
EOL. The underutilization of hospice and home health services, however, represents an opportunity to improve
the quality of EOL care while potentially reducing or remaining budget neutral.
Introduction
As the United States braces for the full implementationof health care reform, the eyes of the nation are on
Medicaid.1 The Medicaid program generally provides com-
prehensive and affordable health care for children and low-
income adults and is jointly financed by federal and state
government. Under the 2010 Patient Protection and Afford-
able Care Act (ACA), Medicaid coverage for individuals will
be expanded and payment to providers modified.2 In light of
these Medicaid changes, concerns have been voiced about
access to health care.1 The large number of newly eligible
Medicaid beneficiaries may challenge health care resources
and ultimately impact quality of care. This is a special concern
among current Medicaid beneficiaries such as children with
complex chronic conditions (CCCs) who have significant
health care needs, especially at end of life (EOL).3
There are more than 100 pediatric deaths in the United
States daily.4 Although many deaths are attributable to acci-
dents and injuries, health-related mortality remains signifi-
cant and typically involves CCCs such as cancer, congenital
anomalies, and circulatory disease.5,6 In California, for ex-
ample, CCCs are the leading cause of death among children
and account for 70% of all pediatric deaths.7 Previous studies
have found that deaths among children with CCCs vary
widely by type of health condition and age group.5,8,9 The
prevalence of children with CCCs in the inpatient hospital
setting has increased,10,11 and their EOL care in this setting is
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highly technical.12 Accordingly, the average cost of health
care services for these children ranges from $62,000 to
$110,000 annually.13
Although existing literature provides knowledge about
children with CCCs, a comprehensive profile of their demo-
graphic and health characteristics, health care utilization, and
expenditures at EOL is lacking. This study begins to fill the
gap by providing a foundational examination of their demo-
graphic and health characteristics, which will provide a more
complete picture of some of the sickest children in our health
care system. In addition, investigating the health care utili-
zation and expenditures of children with CCCs will provide
timely baseline information necessary for policy makers, as
they evaluate the impact of the ACA and ensure quality of
EOL care for Medicaid children in the future. Therefore, the
purpose of this study was to understand the demographic
and health characteristics, health care utilization, and expen-
ditures among Medicaid children with CCCs at EOL.
Methods
Data sources
Administrative data in this retrospective cohort study were
primarily drawn from the 2007 and 2008 California Medicaid
program’s Medicaid Analytic Extract (MAX) files. The MAX
files were prepared by the Center for Medicare and Medicaid
Services from data submitted electronically by all 50 states. The
MAX Person Summary File combines eligibility information,
summary claims, and payment data into one record per enrollee.
Other linked MAX files, such as the Other Services file, provide
detail data on services, payment, and diagnoses. MAX files only
include fee-for-service (FFS) data; thus, services provided in
managed-care delivery systems were excluded. We selected
California because it has the largest number of children enrolled
in Medicaid of any state: 4.4 million.14 We used data from 2007
and 2008 because 2007 was the first year the MAX files included
the Social Security Administration date of death and 2008 was
the latest year for which data were available. Other data sources
included the 2004 United States Department of Agriculture ty-
pology codes for metropolitan residential status that were linked
to the Medicaid data by the child’s residential Federal In-
formation Processing Standard (FIPS) code.
Sample
Children studied were those between the ages of 0 and 20
years, who died between January 1, 2007 and December 31,
2008, and were enrolled in the California Medicaid program
for any part of their last year of life. Children were identified
as having a CCC if they had a diagnosis of a neuromuscular,
cardiovascular, respiratory, renal, gastrointestinal, hemato-
logic, metabolic, congenital, or cancer health condition based
on an International Classification of Diseases, 9th Revision (ICD-
9-CM) code as recommended by Feudtner et al.8 Duplicates
and children who were not California residents were ex-
cluded from the sample. Our final sample size was 1423
children. The University of Tennessee at Knoxville Institu-
tional Review Board approved this study.
Measures
Demographic characteristics included age at death, gender,
race/ethnicity, Medicaid eligibility type, private insurance
status, and location of residence. Health characteristics in-
cluded a binary variable for each of the following CCC di-
agnosis categories in the last year of life: neuromuscular
(brain/spinal cord malformation, intellectual disability, cen-
tral nervous system [CNS] disease, cerebral palsy, epilepsy,
and muscular dystrophy), cardiovascular (heart malforma-
tions, cardiomyopathies, and dysrhythmias), cancer, con-
genital anomalies (chromosomal abnormalities, bone/joint
abnormalities, diaphragm/abdominal abnormalities, and
other abnormalities), respiratory (respiratory malformations,
chronic respiratory disease, and cystic fibrosis), gastrointes-
tinal (congenital anomalies, liver disease, and inflammatory
bowel disease), metabolic (amino acid, carbohydrate, lipid,
storage disorders, and other disorders), hematologic (sickle
cell disease, anemia, hereditary immunodeficiency, and hu-
man immunodeficiency virus [HIV]), and renal (congenital
abnormalities and chronic renal failure). We also counted the
number of CCCs for each child and categorized them from 1
to 4 and higher. Comorbidity was calculated with a weighted
Charlson Comorbidity Index using ICD-9-CM codes. A
weighted Charlson score of 3 or more reflects the presence of
significant medical comorbidity.15
We created six binary measures for health care utilization
by type of service16: hospital inpatient, prescription drugs,
hospice/home health, primary care (i.e., physician, dental,
clinic, and other practioner—chiropractor, podiatrist, psy-
chologist, and optometrist), other acute care (i.e., targeted case
management, rehabilitation, private duty nursing, residential,
psychiatric, therapy, and outpatient hospital), and ancillary
care (i.e., transportation, equipment, lab/X-ray, personal care,
and other services—prosthetics and eyeglasses). Health care
expenditures were the sum of FFS payments to providers in
the child’s last year of life and were analyzed separately by
service type categories. It is common for Medicaid enrollees to
cycle on and off the program because of changes in their
economic or personal circumstances, so expenditures were
adjusted for the time in the Medicaid program during the last
year of life. The expenditure estimates are presented as the
average cost per month enrolled. All expenditure data were
adjusted to 2007 dollars using the Consumer Price Index.
Statistical analysis
The primary aim of our study was to profile children with
CCCs at EOL. Descriptive statistics were calculated on de-
mographic and health characteristics, health care utilization,
and health care expenditures. Additionally, Pearson’s v2 test
for differences in proportions and analyses of variance
(ANOVA) for differences in means were used to provide
comparisons among pediatric age groups. We present our
results in the form of univariate distributions and means.
Analyses were conducted using Stata version 11.0 (StataCorp
LP, College Station, TX).
Results
Table 1 summarizes the demographics of the sample. Boys
(52%) and girls (48%) were evenly represented with consistent
distribution across the age groups. There were no significant
differences between gender by age. The largest racial or ethnic
segment was Hispanic (38%), followed by other races and
ethnicities (37%) and white non-Hispanics (17%). Children
under 1 year of age or 15 to 20 years old were more likely to be
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Hispanic (42%, 47%, respectively), and children aged 1 to 5
and 6 to 14 were more often from other races/ethnicities (53%,
39%, respectively). A majority of children were eligible for
Medicaid through their disability status (68%). Infants were
generally eligible for Medicaid because of their nondisability
status (64%) compared with older children. Relatively few
children received assistance from private health insurance
(11%). It was rare for children younger than 6 to have private
health insurance (3% for children less than 1 year, 8% for 1 to 5
years). The sample resided almost exclusively in urban
counties (99%).
The sample was most often diagnosed with neuromuscular
diseases (54%) and infrequently with renal problems (4%)
(Table 1). A majority of infants under 1 year had cardiovas-
cular conditions (75%), followed by congenital (29%), neuro-
muscular (29%), and respiratory (24%). The most common
conditions among children 1 to 5 years old were cardiovas-
cular (59%), neuromuscular (55%), congenital (34%), cancer
(24%), and respiratory (22%). Neuromuscular (62%, 52%),
cancer (37%, 36%), and cardiovascular (29%, 40%) were the
most frequent CCCs of children 6 to 14 and 15 to 20 years old.
Approximately 44% had one CCC, 28% had two CCCs, 16%
had three CCCs, and 12% had four or more CCCs. Children
aged 1 to 5 years averaged three CCCs. The average Charlson
Comorbidity Index value was 2.19, which indicates a rela-
tively high level of comorbidity. The Charlson Comorbidity
Index score varied significantly by age from 0.72 for infants
under 1 year to more than 2.0 for children older than 1 year
of age.
Table 2 indicates the utilization and expenditures for se-
lected health care services. Total FFS payments in the last year
of life averaged $82,000 per child annually (data not shown).
In keeping with this high level of spending, the sample was
composed of heavy users of health care services. Service uti-
lization was highest in ancillary (87%), acute (83%), and pri-
mary (82%) care services and lowest in hospice and home
health care (26%). Hospital inpatient care and primary care
services dominated health care spending for this group,
comprising 82% of the expenditures.
Approximately two-thirds of the children in the sample
were hospitalized in the last year of life with an average cost of
$10,753 per month, which is the highest spending category.
Children under 6 years of age were slightly more likely to have
been hospitalized (77% for ages less than 1 year, 75% for ages 1
to 5, 59% for ages 6 to 14, 62% for ages 15 to 20, respectively),
and their expenditures were almost twice that of older children
($15,630/month, $13,545/month, $8,436/month, and $8,374/
month, respectively). Although utilization of prescription
Table 1. Demographic and Health Characteristics of Children with Complex Chronic Conditions
at End of Life by Age Group
All children < 1 year 1–5 years 6–14 years 15–20 years
Characteristics (n = 1423) (n = 133) (n = 463) (n = 412) (n = 415) P value
Demographic characteristics
Gender
Male (%) 52.42 53.38 48.81 52.43 56.14 0.189
Female (%) 47.58 46.62 51.19 47.57 43.86
Race/ethnicity
White non-Hispanic (%) 16.58 9.77 9.29 17.72 25.78 0.001
Black non-Hispanic (%) 7.94 10.53 6.26 7.52 9.40
Hispanic (%) 38.16 42.11 31.32 35.92 46.75
Other (%) 37.32 37.59 53.13 38.84 18.07
Medicaid eligibility
Disabled (%) 67.53 36.09 64.79 81.07 67.23 0.001
Nondisabled (%) 32.47 63.91 35.21 18.93 32.77
Private insurance (%) 11.31 3.01 7.78 15.78 13.49 0.001
Residence
Urban (%) 98.59 98.50 98.27 98.79 98.80 0.899
Rural (%) 1.41 1.50 1.73 1.21 1.20
Health characteristics
Complex chronic conditions (CCCs)
Neuromuscular (%) 53.83 29.32 54.64 62.38 52.29 0.001
Cardiovascular (%) 46.38 75.19 59.61 28.88 39.76 0.001
Cancer (%) 29.87 7.52 23.97 37.14 36.39 0.001
Congenital (%) 22.84 29.32 34.34 18.93 11.81 0.001
Respiratory (%) 12.30 24.06 22.25 7.28 2.41 0.001
Gastrointestinal (%) 12.02 10.53 16.63 8.98 10.36 0.003
Metabolic (%) 10.40 7.52 12.10 8.74 11.08 0.257
Hematologic (%) 8.85 4.51 11.45 7.52 8.67 0.048
Renal (%) 4.08 4.51 9.50 1.00 1.20 0.001
Number of CCCs
One CCC (%) 44.06 44.36 30.67 49.27 53.73 0.001
Two CCCs (%) 28.25 33.08 26.78 29.61 26.99
Three CCCs (%) 15.95 12.03 20.52 14.56 13.49
Four or more CCCs (%) 11.74 10.53 22.03 6. 55 5.78
Avg. Charlson Comorbidity Index 2.19 0.72 2.08 2.48 2.51 0.001
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drugs was relatively high (65%), expenditures on prescription
drugs were some of the lowest ($498/month). Infants under 1
year of age were significantly less likely to utilize prescription
drugs than were children over 1 year of age (45%, 63%, 74%,
and 65%, respectively). Additionally, infant health care
spending on prescription drugs was low compared with the
other children ($47, $471, $631, and $539, respectively).
Hospice and home health services were the least utilized
services and the smallest spending category. Only 26% of the
sample used hospice or home health services with an average
monthly cost of $466, and there were no differences in utili-
zation by age. Average monthly home health and hospice
expenditures, however, varied significantly from $727 per
month for children 6 to 14 years old to $175 per month for
infants under 1 year old. The second highest expenditure
category was primary care. More than 80% of children visited
physicians, dentists, and other practitioners, and this care
accounted for 6% of total spending. Children under 6 years
old were significantly more likely to have used primary care
services compared with the older age groups (93%, 87%, 80%,
and 76%, respectively). Indeed, this group incurred twice the
costs in primary care services as did the older children ($1,472,
$1,017, $683, and $711, respectively).
After primary care services, expenditures for other acute
care was the next largest spending category. More than 80% of
children used other acute care services. The average spending
on other acute care services was $803 per month. Children 6 to
14 years old were more likely to use acute care services (88%),
and children 15 to 20 years old were least likely to utilize these
services (77%). However, infants under 1 year of age had the
highest other acute care expenditures of any age group
($1,327/month). Ancillary services were the most frequently
utilized service (87%), and they cost approximately $750 per
month. Although there was no difference in utilization by age
group, the cost of ancillary services for children over 6 years of
age was almost 3 times higher than for younger children.
Discussion
The primary goal of our study was to provide a profile of
the demographic and health characteristics, health care utili-
zation, and expenditures of children with CCCs at EOL, and
we sought to compare differences in these factors based on
pediatric age groups. From the analysis of California’s Med-
icaid data, we found a diverse group of children who suffered
with serious, multiple chronic conditions, and who accessed
comprehensive, multidisciplinary care.
Children with CCCs in the study were medically complex.
Neuromuscular conditions such as intellectual disabilities,
brain/spinal cord malformation, CNS disease, cerebral palsy,
muscular dystrophy, and epilepsy were very prevalent among
this group of children. Our results are consistent with other
researchers who found that neuromuscular conditions were
common among children with CCCs and reports that the
number of children with neurodevelopment disabilities has
climbed over the past decade to nearly 1 in 6.17,18 In addition,
these children suffered from multiple CCCs. We found that
more than 50% of the children had two or more CCCs, which
was higher than Feudtner et al. reported in their study of
hospitalized children with CCCs.9 These health findings sug-
gest that children in our sample may be very medically fragile.
Indeed, the nature of their impairments and the presence of
multiple CCCs may complicate the care children receive at
EOL. Children and their families may encounter communica-
tion issues with clinicians about medical decisions and care
goals,19,20 poor care coordination,21,22 and problems with
prognosis.23 Therefore, it may be challenging for children with
complicated disease processes to receive quality EOL care.
Table 2. Health Care Utilization and Expenditures among Children with Complex Chronic
Conditions at End of Life by Age Group
All children Under 1 year 1–5 years 6–14 years 15–20 years
Health care services (n = 1423) (n = 133) (n = 463) (n = 412) (n = 415) P value
Hospital inpatient care
Used services (%) 66.55 76.69 74.51 58.50 62.41 0.001
Avg. monthly expenditures $10,753 $15,630 $13,545 $8,436 $8,374 0.001
Prescription drugs
Used services (%) 65.21 45.11 63.28 74.03 65.06 0.001
Avg. monthly expenditures $498 $47 $471 $631 $539 0.001
Hospice/Home health care
Used services (%) 25.58 23.31 28.29 27.67 21.20 0.064
Avg. monthly expenditures $466 $175 $337 $727 $444 0.001
Primary carea
Used services (%) 82.29 93.23 87.26 79.61 75.90 0.001
Avg. monthly expenditures $874 $1,472 $1,017 $683 $711 0.001
Other acute careb
Used services (%) 83.13 81.20 85.53 87.62 76.63 0.001
Avg. monthly expenditures $803 $1,327 $884 $828 $519 0.001
Ancillary carec
Used services (%) 87.42 84.96 86.83 90.05 86.27 0.265
Avg. monthly expenditures $751 $297 $569 $927 $923 0.001
aPrimary care included physician, dental, clinic, and other practitioners (chiropractors, podiatrists, psychologists, and optometrists).
bOther acute care included targeted case management, rehabilitation, private duty nursing, residential, psychiatric, therapy, and outpatient
hospital.
cAncillary care included transportation, equipment, lab/X-ray, personal care, and other services (prosthetics and eyeglasses).
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Children with CCCs generally received comprehensive
care including hospital inpatient, primary, ancillary, and
other acute care services; however, very few children utilized
hospice and home health care services. Only 356 or 25% of
children in the study accessed care designed to meet the
physical and psychosocial needs of terminally ill children and
their families. In a white paper produced by the Children’s
International Project on Palliative/Hospice Services (ChiPPS)
for the National Hospice and Palliative Care Organization
(NHPCO), experts in the field of pediatric, EOL care reported
that less than 10% of children receive hospice care.24 Others
have drawn similar conclusions in studies of children with
cancer and acquired immune deficiency syndrome
(AIDS).25,26 One possible reason for the low utilization may be
families’ acceptance of the child’s prognosis. The impending
death of a child may be difficult for families to acknowledge
and thus may prevent the initiation of EOL care.27 An alter-
native explanation may relate to clinicians’ referral practices
to pediatric hospice and home health care. Pediatric clinicians
generally lack an understanding of and experience with pe-
diatric EOL care. Most physicians have limited or no training
in core EOL competencies,28,29 less than 50% of residents are
taught how to hold conversations about pediatric EOL,29 and
more than 25% of pediatricians do not even know whether
local pediatric hospice services exist.30 Finally, obtaining
hospice and home health care may also depend on whether or
not organizations provide care for children. Our previous
research has shown that approximately two-thirds of Cali-
fornia hospices and home health agencies do not provided
pediatric EOL care, and the percentage of agencies providing
care for children has declined from 40% in 2002 to 28% in
2008.31 Thus, children with CCCs may not be receiving high-
quality EOL care. Future research design should explore and
clarify the influence of child demographic and health char-
acteristics on EOL care utilization.
There are several limitations of this study to note including
the lack of information on cause of death, symptoms, and
family characteristics in the Medicaid files dataset. However,
Medicaid paid claims require providers report data for re-
imbursement. As a result, there is an incentive for complete
and accurate data.32 The focus was on a sample of pediatric
patients who were eligible for FFS Medicaid in California, so
the findings are not generalizable. However, California has
the largest population of children enrolled in Medicaid at 4.4
million and California Medicaid policies and practices are
often a model for other states.14 Finally, the use of a Medicaid
dataset is a limitation because children less than 1 year of age
may be less likely to have been enrolled in Medicaid prior to
death, as previous studies have shown they have the highest
mortality.4
Nevertheless, our data may contribute to current and fu-
ture discussions regarding health policy for children with
CCCs by advancing our knowledge and understanding of
hospice and home health services for them, underscoring the
relevance of recent policy efforts to update the Medicaid and
Children’s Health Insurance Benefit (CHIP) hospice benefit
for children. Section 2302 Concurrent Care for Children be-
came law with the passage of health care reform. Concurrent
Care permits children on the Medicaid or CHIP hospice
benefit to continue receiving treatments related to their ter-
minal illness (e.g., chemotherapy, dialysis, antiretroviral reg-
imens, and radiation).33 The intent of health care reform was
to improve access to and ultimately quality of EOL care by
eliminating a hospice eligibility criteria,34 a need further
supported by the results of this study, which indicate that
prior to the ACA children generally did not utilize hospice
and home health services at EOL. Due to the staggered im-
plementation schedule of ACA provisions, future research
might compare the influence of ACA 2302 with other health
care reform provisions such as Medicaid expansion on access
to hospice and home health care among children at EOL using
longitudinal data. Our study provides critical baseline data
for future research on the impact of health policy aimed at
Medicaid and CHIP children. Therefore, the change in the
federal law to allow concurrent curative care may be an im-
portant health care reform policy initiative aimed at improv-
ing the utilization and quality of care for children at EOL.
Conclusion
This study is the first to profile children with CCCs in the
last year of life. As states continue to be challenged to provide
quality health care to a growing Medicaid population in spite
of decreased allocation of resources and the nation prepares
for full implementation of health care reform in 2014, this
analysis is timely. The current Medicaid FFS payment system
in California appears to be providing comprehensive care for
children and their families. Nevertheless, the underutilization
of hospice and home health services, with their consistently
low average monthly cost, represents an opportunity to im-
prove the quality of EOL care while potentially reducing or
remaining budget neutral.
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